We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The U.S. Army's decision to transfer a Zika vaccine candidate's license to development partner Sanofi has prompted protest from a nonprofit worried about the legality of the plan and the product's future pricing.